NCPA Backs New Senate Bill to End Retroactive 'DIR Fees,' Improve Medicare Transparency
September 12th 2016Four U.S. Senators today introduced bipartisan legislation to boost transparency in Medicare Part D drug spending and to prohibit retroactive "DIR fees" in response to concerns raised by National Community Pharmacists Association (NCPA) members and staff.
Read More